Compound details
4-{7-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-9a-[(dodecylimino)methyl]-3a,5a-dihydroxy-11a-methyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl}-2,5-dihydrofuran-2-one
| Compound ID | CDAMM00231 |
|---|---|
| Common name | 4-{7-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-9a-[(dodecylimino)methyl]-3a,5a-dihydroxy-11a-methyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl}-2,5-dihydrofuran-2-one | IUPAC name | 3-[3-(4,5-dihydroxy-6-methyloxan-2-yl)oxy-10-(dodecyliminomethyl)-5,14-dihydroxy-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one |
| Molecular formula | C41H67NO8 |
| Retention time | 39.12 |
|---|---|
| Adduct | [M+Na]+ |
| Actual mz | 724.475 | Theoretical mz | 724.476 |
| Error | 0.93 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.5328 |
| Inchi key | BFHMKTVRGVIFNE-UHFFFAOYSA-N |
|---|---|
| Smiles | CCCCCCCCCCCCN=CC12CCC(CC1(CCC3C2CCC4(C3(CCC4C5=CC(=O)OC5)O)C)O)OC6CC(C(C(O6)C)O)O |
| Superclass | Lipids and lipid-like molecules |
| Class | Steroids and steroid derivatives |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T40800 | DI0068 | Cardiac arrhythmia | [ICD-11: BC9Z] | P05023 | ATP1A1 |
| T40800 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P05023 | ATP1A1 |
| T40800 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P05023 | ATP1A1 |
| T40800 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P05023 | ATP1A1 |
| T40800 | DI0186 | Hyperhidrosis | [ICD-11: EE00] | P05023 | ATP1A1 |
| T40800 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P05023 | ATP1A1 |
| T40800 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P05023 | ATP1A1 |